Skip to content

Lycia Therapeutics, Inc.

LYCA· Nasdaqneeds manual mappingCIK 1806540

Biological products, except diagnostic substances176 peers

Last sale
Nov 12, 2026 · +2.18%
Market cap
—
no share count on file
Filings
40
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—

Price

$32.74+9.13%+$2.74since Oct 23, 2026
Nov 12, 2026 · IEX last sale
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

No financial figures on file for LYCA yet.

Biological products, except diagnostic substances

176 covered companies are filed under this code. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, largest by revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Lycia Therapeutics, Inc. · CIK 1806540 · Engraved from SEC EDGAR